Pr ecis: These findings show how an EGF receptor antibody used widely in the clinic actually induces a self-attenuating mechanism of drug resistance by stimulating cell-ECM interactions that block therapeutic efficacy.
Pr ecis: IL-10 provided by T cells in the colon is critical to control bacterial-driven inflammation and polyp growth, providing a rationale for this cytokine as a candidate target for immunotherapy in colon cancer. Pr ecis: These findings define a novel role for the Notch1 receptor in lung cancer, offering a molecular basis for observations related to patient prognosis and reinforcing the notion that Notch1 is a worthy therapeutic target in this setting. 
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